4//SEC Filing
Smith-Whitley Kim 4
Accession 0000899243-22-030478
CIK 0001629137other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 7:00 PM ET
Size
9.3 KB
Accession
0000899243-22-030478
Insider Transaction Report
Form 4
Smith-Whitley Kim
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-09-01+2,208→ 6,588 total - Exercise/Conversion
Restricted Stock Units
2022-09-01−2,208→ 15,460 total→ Common Stock (2,208 underlying) - Tax Payment
Common Stock
2022-09-01$68.15/sh−607$41,367→ 5,981 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 2,208 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2022, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001860297
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 7:00 PM ET
- Size
- 9.3 KB